Cold Plasma Market
Description
Cold Plasma Market Size, Share & Trends Analysis Report By Pressure, By Application (Wound Healing, Blood Coagulation, Dentistry, Cancer Treatment, Other Medical Applications), By Region, And Segment Forecasts, 2026 - 2033
Cold Plasma Market Summary
The global cold plasma market size was estimated at USD 167.8 million in 2025 and is projected to reach USD 495.9 million by 2033, growing at a CAGR of 14.6% from 2026 to 2033. This growth is attributed to the overall development of the healthcare industry, which has increased the demand for advanced technologies to enhance patient treatment procedures and make them safe and non-invasive.
In addition, cold plasma technology enhances applications such as cancer treatment, sterilization, and wound healing, driving the market's growth significantly. Cold plasma, also known as non-equilibrium plasma, is a partially ionized gas in which the temperatures of its constituents differ significantly. It is generated by supplying energy to gases, creating reactive species useful in various applications, including medical treatments, sterilization, and food safety, without the harmful effects of high-temperature plasmas.
According to research by the University of Michigan, cold plasma is the most effective solution for removing dangerous airborne viruses. Non-thermal plasma can remove up to 99% of the virus in fractions of a second. This creates opportunities for doctors to treat patients with breathing problems using cold plasma technologies.
Increasing applications across various industries, including textiles, food safety, and medical sectors, significantly contribute to market growth. In addition, the rising demand for sustainable and efficient processing technologies, alongside innovations in food decontamination and medical treatments, further fuels this growth. Furthermore, the market is supported by advancements in atmospheric cold plasma technology, which offers eco-friendly solutions without harmful chemicals, enhancing its attractiveness to diverse industries.
The rising incidence of hospital-acquired infections (HAIs) is a critical driver of the cold plasma market, as healthcare facilities seek effective solutions for infection control and sterilization. For instance, according to the World Health Organization (WHO), HAIs affect hundreds of millions of patients worldwide each year, leading to increased morbidity, extended hospital stays, and higher healthcare costs. In the United States alone, the Centers for Disease Control and Prevention (CDC) estimates that about 1 in 31 hospital patients has at least one HAI on any given day, contributing to approximately 99,000 deaths annually.
Rising cases of hospital-acquired infections (HAIs) are significantly driving the growth of the cold plasma market. Cold plasma technology is increasingly recognized for its effective antimicrobial properties, making it a valuable solution for infection control and sterilization in healthcare settings. As hospitals strive to reduce HAIs and enhance patient safety, the demand for innovative technologies like cold plasma continues to rise. For instance, according to the Global Report on Infection Prevention and Control (2024) by the World Health Organization (WHO), out of every 100 patients in acute-care hospitals, 7 patients in high-income countries (HICs) and 15 patients in low-income countries (LMICs) acquired at least one HAI during their hospital stay.
Global Cold Plasma Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and analyzes the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global cold plasma market report based on pressure, application, and region.
Cold Plasma Market Summary
The global cold plasma market size was estimated at USD 167.8 million in 2025 and is projected to reach USD 495.9 million by 2033, growing at a CAGR of 14.6% from 2026 to 2033. This growth is attributed to the overall development of the healthcare industry, which has increased the demand for advanced technologies to enhance patient treatment procedures and make them safe and non-invasive.
In addition, cold plasma technology enhances applications such as cancer treatment, sterilization, and wound healing, driving the market's growth significantly. Cold plasma, also known as non-equilibrium plasma, is a partially ionized gas in which the temperatures of its constituents differ significantly. It is generated by supplying energy to gases, creating reactive species useful in various applications, including medical treatments, sterilization, and food safety, without the harmful effects of high-temperature plasmas.
According to research by the University of Michigan, cold plasma is the most effective solution for removing dangerous airborne viruses. Non-thermal plasma can remove up to 99% of the virus in fractions of a second. This creates opportunities for doctors to treat patients with breathing problems using cold plasma technologies.
Increasing applications across various industries, including textiles, food safety, and medical sectors, significantly contribute to market growth. In addition, the rising demand for sustainable and efficient processing technologies, alongside innovations in food decontamination and medical treatments, further fuels this growth. Furthermore, the market is supported by advancements in atmospheric cold plasma technology, which offers eco-friendly solutions without harmful chemicals, enhancing its attractiveness to diverse industries.
The rising incidence of hospital-acquired infections (HAIs) is a critical driver of the cold plasma market, as healthcare facilities seek effective solutions for infection control and sterilization. For instance, according to the World Health Organization (WHO), HAIs affect hundreds of millions of patients worldwide each year, leading to increased morbidity, extended hospital stays, and higher healthcare costs. In the United States alone, the Centers for Disease Control and Prevention (CDC) estimates that about 1 in 31 hospital patients has at least one HAI on any given day, contributing to approximately 99,000 deaths annually.
Rising cases of hospital-acquired infections (HAIs) are significantly driving the growth of the cold plasma market. Cold plasma technology is increasingly recognized for its effective antimicrobial properties, making it a valuable solution for infection control and sterilization in healthcare settings. As hospitals strive to reduce HAIs and enhance patient safety, the demand for innovative technologies like cold plasma continues to rise. For instance, according to the Global Report on Infection Prevention and Control (2024) by the World Health Organization (WHO), out of every 100 patients in acute-care hospitals, 7 patients in high-income countries (HICs) and 15 patients in low-income countries (LMICs) acquired at least one HAI during their hospital stay.
Global Cold Plasma Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and analyzes the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global cold plasma market report based on pressure, application, and region.
- Pressure Outlook (Revenue, USD Million, 2021 - 2033)
- Low-Pressure Cold Plasma
- Atmospheric Pressure Cold Plasma
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Wound Healing
- Blood Coagulation
- Dentistry
- Cancer Treatment
- Other Medical Applications
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East and Africa (MEA)
- Saudi Arabia
- UAE
- South Africa
- Kuwait
Table of Contents
100 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
- Chapter 3. Cold Plasma Market Variables, Trends, & Scope
- 3.1. Market Introduction/Lineage Outlook
- 3.2. Market Size and Growth Prospects (USD Million)
- 3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
- 3.4. Cold Plasma Market Analysis Tools
- 3.4.1. Porter’s Analysis
- 3.4.1.1. Bargaining power of the suppliers
- 3.4.1.2. Bargaining power of the buyers
- 3.4.1.3. Threats of substitution
- 3.4.1.4. Threats from new entrants
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Economic and Social landscape
- 3.4.2.3. Technological landscape
- 3.4.2.4. Environmental landscape
- 3.4.2.5. Legal landscape
- Chapter 4. Cold Plasma Market: Pressure Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Global Cold Plasma Market: Pressure Movement Analysis, 2025 & 2033 (USD Million)
- 4.3. Low-Pressure Cold Plasma
- 4.3.1. Low-Pressure Cold Plasma Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4. Atmospheric Pressure Cold Plasma
- 4.4.1. Atmospheric Pressure Cold Plasma Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 5. Cold Plasma Market: Application Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Cold Plasma Market: Application Movement Analysis, 2025 & 2033 (USD Million)
- 5.3. Wound Healing
- 5.3.1. Wound Healing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.4. Blood Coagulation
- 5.4.1. Blood Coagulation Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.5. Dentistry
- 5.5.1. Dentistry Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.6. Cancer Treatment
- 5.6.1. Cancer Treatment Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.7. Other Medical Applications
- 5.7.1. Other Medical Applications Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 6. Cold Plasma Market: Regional Estimates & Trend Analysis
- 6.1. Cold Plasma Market Share, By Region, 2025 & 2033 (USD Million)
- 6.2. North America
- 6.2.1. North America Cold Plasma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.2.2. U.S.
- 6.2.2.1. U.S. Cold Plasma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.2.3. Canada
- 6.2.3.1. Canada Cold Plasma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.2.4. Mexico
- 6.2.4.1. Mexico Cold Plasma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.3. Europe
- 6.3.1. Europe Cold Plasma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.3.2. UK
- 6.3.2.1. UK Cold Plasma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.3.3. Germany
- 6.3.3.1. Germany Cold Plasma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.3.4. France
- 6.3.4.1. France Cold Plasma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.3.5. Italy
- 6.3.5.1. Italy Cold Plasma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.3.6. Spain
- 6.3.6.1. Spain Cold Plasma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.3.7. Denmark
- 6.3.7.1. Denmark Cold Plasma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.3.8. Sweden
- 6.3.8.1. Sweden Cold Plasma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.3.9. Norway
- 6.3.9.1. Norway Cold Plasma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.4. Asia Pacific
- 6.4.1. Asia Pacific Cold Plasma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.4.2. China
- 6.4.2.1. China Cold Plasma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.4.3. Japan
- 6.4.3.1. Japan Cold Plasma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.4.4. India
- 6.4.4.1. India Cold Plasma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.4.5. South Korea
- 6.4.5.1. South Korea Cold Plasma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.4.6. Australia
- 6.4.6.1. Australia Cold Plasma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.4.7. Thailand
- 6.4.7.1. Thailand Cold Plasma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5. Latin America
- 6.5.1. Latin America Cold Plasma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.2. Brazil
- 6.5.2.1. Brazil Cold Plasma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.3. Argentina
- 6.5.3.1. Argentina Cold Plasma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.6. Middle East and Africa
- 6.6.1. Middle East and Africa Cold Plasma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.6.2. Saudi Arabia
- 6.6.2.1. Saudi Arabia Cold Plasma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.6.3. UAE
- 6.6.3.1. UAE Cold Plasma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.6.4. South Africa
- 6.6.4.1. South Africa Cold Plasma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.6.5. Kuwait
- 6.6.5.1. Kuwait Cold Plasma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis by Key Market Participants
- 7.2. Company Categorization
- 7.3. Company Heat Map Analysis
- 7.4. Company Profiles
- 7.4.1. Apyx Medical.
- 7.4.1.1. Participant’s Overview
- 7.4.1.2. Financial Performance
- 7.4.1.3. Product Benchmarking
- 7.4.1.4. Recent Developments/ Strategic Initiatives
- 7.4.2. Neoplas med GmbH
- 7.4.2.1. Participant’s Overview
- 7.4.2.2. Financial Performance
- 7.4.2.3. Product Benchmarking
- 7.4.2.4. Recent Developments/ Strategic Initiatives
- 7.4.3. Adtec Healthcare Limited
- 7.4.3.1. Participant’s Overview
- 7.4.3.2. Financial Performance
- 7.4.3.3. Product Benchmarking
- 7.4.3.4. Recent Developments/ Strategic Initiatives
- 7.4.4. Terraplasma GmbH.
- 7.4.4.1. Participant’s Overview
- 7.4.4.2. Financial Performance
- 7.4.4.3. Product Benchmarking
- 7.4.4.4. Recent Developments/ Strategic Initiatives
- 7.4.5. CINOGY System GmbH;
- 7.4.5.1. Participant’s Overview
- 7.4.5.2. Financial Performance
- 7.4.5.3. Product Benchmarking
- 7.4.5.4. Recent Developments/ Strategic Initiatives
- 7.4.6. Plasmacure.
- 7.4.6.1. Participant’s Overview
- 7.4.6.2. Financial Performance
- 7.4.6.3. Product Benchmarking
- 7.4.6.4. Recent Developments/ Strategic Initiatives
- 7.4.7. Relyon Plasma GmbH.
- 7.4.7.1. Participant’s Overview
- 7.4.7.2. Financial Performance
- 7.4.7.3. Product Benchmarking
- 7.4.7.4. Recent Developments/ Strategic Initiatives
- 7.4.8. US Medical Innovations
- 7.4.8.1. Participant’s Overview
- 7.4.8.2. Financial Performance
- 7.4.8.3. Product Benchmarking
- 7.4.8.4. Recent Developments/ Strategic Initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
